Erlotinib in the trentment of Advanced Non-small-cell Lung Cancer: A Systematic Review
Background and objective Erlotinib is a new and efficient anti-tumor targeted therapy drug, and it has been used in China for non-small cell lung cancer since 2006. The aim of this study is to review the effectiveness and safety of erlotinib for treating advanced non-small cell lung cancer. Methods...
I tiakina i:
| Ngā kaituhi matua: | , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Chinês |
| I whakaputaina: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2009-12-01
|
| Rangatū: | Chinese Journal of Lung Cancer |
| Ngā marau: | |
| Urunga tuihono: | http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2009.12.02&path[]=1226 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|